Lv12
70 积分 2024-11-13 加入
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
1天前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
6天前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
7天前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
7天前
已完结
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
7个月前
已完结
皖公网安备34019202002308
